2 min read
Fasolamin – Action and Side Effects
1 photo
736
Smart Voice
AI
0:00
0:00
Listen to the article content live
Table of Contents 3
Fasolamin, a biologically active chemical compound found in white and red beans, is a glycoprotein that was discovered in 1975. Currently, it is widely sold as dietary supplements to support weight loss. However, the claims that fasolamin prevents the 'accumulation of carbohydrates in the form of excess fat tissue' are controversial and provocative. In reality, the action of this compound is significantly more complex.
01 / 03
Phasolamines and their bioactive derivatives: Composition, functional properties, and mechanistic insights
Leguminous plants, specifically white and red bean varieties from which phasolamines are extracted, belong to the *Fabaceae* family and are recognized as both economically viable and nutritionally dense food sources. These species are distinguished by their affordability, high content of complete plant-based protein, dietary fiber, and select B-complex vitamins. Beyond these macronutrients, beans harbor an array of phytochemicals, among which phasolamine—a polyphenolic compound—stands out not only for its capacity to scavenge reactive oxygen species (exhibiting antioxidant activity) but also for its mechanistically distinct influence on metabolic pathways within the human body.
02 / 03
Phasolamine: Mechanistic influence on carbohydrate digestion and metabolic regulation
Phasolamine is distinguished by its capacity to selectively inhibit the enzymatic activity of alpha-amylase—a protein responsible for catalyzing the hydrolysis of complex carbohydrates, including starch. Its mechanism of action involves blocking the function of this enzyme, thereby resulting in a diminished ability of the gastrointestinal tract to fully degrade polysaccharides. Due to this specific property, phasolamine has gained recognition as a component in dietary supplements, though it is important to emphasize that supplementation alone does not ensure weight loss. However, it may assist in maintaining stable blood glucose levels, which is particularly relevant for individuals with insulin resistance or type 2 diabetes. Furthermore, research indicates that phasolamine exhibits antioxidant activity, protecting cells from oxidative damage, which could contribute to improved metabolic parameters in individuals with obesity or other metabolic disorders.
03 / 03
Fazolamine-induced adverse reactions: Enzymatic carbohydrate blockade and its systemic consequences
Disrupting the natural activity of digestive enzymes—particularly those responsible for the breakdown of complex carbohydrates—almost invariably carries the risk of adverse effects. Supplementation with fazolamine, an extract derived from white and red kidney beans and commonly marketed as an alpha-amylase inhibitor, may induce gastrointestinal dysfunctions manifesting as abdominal pain of varying severity, recurrent diarrhea, persistent constipation, excessive intestinal gas accumulation, and impaired glucose homeostasis in response to starch-rich meals. Prolonged use may lead to deficiencies in micro- and macronutrients, generalized physical weakness, and diminished absorption efficiency of essential dietary components. Beans, a dietary staple in numerous cultures, naturally contain fazolamine—a compound that, in its concentrated supplemental form, has gained traction among individuals seeking adjunctive support for weight management, particularly when conventional approaches such as caloric restriction or lifestyle modifications prove inadequate.
Meal Plan
Want to apply these guidelines in your daily diet?
Our smart diet generator creates a tailored meal plan in 3 minutes based on the recommendations in this article.
Tags
Scientifically reviewed by a clinical dietitian
• 25.09.2026
Literatura: Barrett M.L., Udani J.K.: A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 2011 Mar 17;10:24. de Gouveia N.M., Alves F.V., i wsp.: An in vitro and in vivo study of the α-amylase activity of phaseolamin. J Med Food. 2014 Aug;17(8):915-20. Oliveira R.J., de Oliveira V.N., i wsp.: Phaseolamin treatment prevents oxidative stress and collagen deposition in the hearts of streptozotocin-induced diabetic rats. Diab Vasc Dis Res. 2014 Mar;11(2):110-7.
Diets Premium Expert
Diets Premium team expert. Specializes in nutrition plans, strength sports, and training plans.
USDA FoodData Central
EFSA
PubMed Clinical Guidelines
